Letronat - Letrozole 2.5mg Tablets For Breast Cancer And Infertility | Aromatase Inhibitor, 20 Unit Box, For Women

Name: LETRONET 2.5 TAB
Availability: InStock

Price Trend: 25.96-28.70 USD / Box

Get Latest Price

Minimum Order Quantity :

10 Box

Brand Name :

Letronat Tab

Drug Type	Specific Drug
Ingredients	LETROZOLE 2.5MG
Physical Form	Tablets
Function	Cancer Treatment
Recommended For	BREAST CANCER,INFERTILITY DUE TO ANOVULATION
Dosage	dult and elderly patients The recommended dose of Letrozole Tablets is 2.5 mg once daily. No dose adjustment is required for elderly patients. In patients with advanced or metastatic breast cancer, treatment with Letrozole Tablets should continue until tumour progression is evident. In the adjuvant and extended adjuvant setting, treatment with Letrozole Tablets should continue for 5 years or until tumour relapse occurs, whichever is first. In the adjuvant setting a sequential treatment schedule (letrozole 2 years followed by tamoxifen 3 years) could also be considered (see sections 4.4 and 5.1). In the neoadjuvant setting, treatment with Letrozole tablet could be continued for 4 to 8 months in order to establish optimal tumour reduction. If the response is not adequate, treatment with Letrozole tablet should be discontinued and surgery scheduled and/or further treatment options discussed with the patient.
Suitable For	Women
Quantity	20 UNITS Boxes
Storage Instructions	ROOM TEMP. 10 -30 C
Payment Terms	Cash in Advance (CID)
Supply Ability	100 Per Week
Delivery Time	2 Week
Packaging Details	1*10S
Main Export Market(s)	North America, Eastern Europe, Western Europe, Middle East, Africa, Central America, South America, Asia, Australia
Main Domestic Market	All India